InspireMD market cap is $10.6 m, and annual revenue was $3.72 m in FY 2019

InspireMD Gross profit (Q2, 2020)-120 K

InspireMD Gross profit margin (Q2, 2020), %(38.3%)

InspireMD Net income (Q2, 2020)-2.5 M

InspireMD EBIT (Q2, 2020)-2.4 M

InspireMD Cash, 30-Jun-202013.9 M

InspireMD EV-2.8 M

InspireMD revenue was $3.72 m in FY, 2019

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 6.0m | 2.1m | 3.1m | 2.8m | 2.3m | 1.9m | 2.8m | 3.6m | 3.7m |

| (26%) | (18%) | |||||||

## Cost of goods sold | 3.0m | 1.4m | 1.4m | 2.0m | 2.6m | 1.8m | 2.2m | 2.6m | 3.0m |

## Gross profit | 3.0m | 694.0k | 1.7m | 784.0k | (296.0k) | 102.0k | 585.0k | 995.0k | 756.0k |

| 50% | 34% | 54% | 28% | (13%) | 5% | 21% | 28% | 20% |

## Sales and marketing expense | 2.0m | 1.2m | 2.6m | 6.6m | 3.2m | 1.5m | 2.4m | 2.2m | 2.4m |

## R&D expense | 2.5m | 2.6m | 3.3m | 8.7m | 3.6m | 1.3m | 1.3m | 1.5m | 3.0m |

## General and administrative expense | 12.3m | 4.0m | 4.5m | 9.1m | 6.4m | 5.0m | 5.2m | 4.8m | 5.2m |

## Operating expense total | 16.7m | 7.9m | 10.5m | 24.5m | 14.2m | 7.8m | 8.8m | 8.6m | 10.6m |

## EBIT | (13.7m) | (7.2m) | (8.8m) | (23.7m) | (14.5m) | (7.6m) | (8.2m) | (7.6m) | (9.8m) |

| (229%) | (346%) | (284%) | (841%) | (627%) | (404%) | (298%) | (211%) | (264%) |

## Interest expense | 24.0k | 1.2m | 273.0k | 1.4m | 1.0m | 721.0k | 119.0k | ||

## Interest income | 9.0k | ||||||||

## Pre tax profit | (14.7m) | (7.0m) | (9.3m) | (25.1m) | (15.6m) | (8.5m) | (8.4m) | (7.2m) | (10.0m) |

## Income tax expense | 2.0k | 32.0k | 10.0k | 12.0k | 4.0k | 1.0k | 27.0k | 24.0k | |

## Net Income | (14.7m) | (7.1m) | (9.3m) | (25.1m) | (15.6m) | (8.5m) | (8.4m) | (7.2m) | (10.0m) |

USD | Q2, 2011 |
---|---|

## Financial Leverage | 1.6 x |